drugset / Trial / NCT02722772

Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee Osteoarthritis

NCT02722772

RandomizedParallel-groupOpen-labelTreatment

Summary

Primary aim: evaluate efficacy of intra-articular injection of etanercept for moderate and severe knee osteoarthritis. Second aim: investigate the potentiality of serum cytokines (TNF-α, Interleukin 1-α (IL1-α), IL1-β, matrix metalloproteinases1 (MMP1), MMP13) to predict the response of intra-articular injection of etanercept for moderate and severe knee osteoarthritis.

Timeline

Start
2016-02
Primary completion
2017-07
Completion
2017-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic 25 mg Other

Indications